news, journals and articles from all over the world.
Taller people have an increased risk of developing atrial fibrillation, according to a new Penn Medicine study. The research is the among the first to demonstrate that height may be a causal—not correlated—risk factor for AFib.
Read moreResearchers from Penn compare a lymphoma-dose regimen of rituximab to a rheumatoid arthritis regimen for the treatment of pemphigus.
Read moreAn international team of experts led by researchers in the Perelman School of Medicine at the University of Pennsylvania and University of Glasgow has been awarded a $9.7 million, five-year grant from the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute for Aging (NIA) to establish CONNECT-TBI—a program spanning 12 institutions which will study traumatic brain injury (TBI) and related neurodegenerative diseases.
Read moreThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs that have not yet been approved by the Food and Drug Administration (FDA). Many in the oncology community say Right to Try strips away important regulatory protections and view the move as a risky step bound to create ethical dilemmas for physicians whose goal is to guide patients toward safe and appropriate treatment decisions. Oncology is one field at the forefront of requests for unapproved drugs. An interdisciplinary team of bioethicists, oncologists, and lawyers from Penn Medicine and other institutions penned a commentary published online this week in the Journal of Clinical Oncology to offer recommendations to help oncologists navigate this new “Right to Try” world, while maintaining their ethical obligations to patients.
Read moreAs part of an effort to improve long-term outcomes, a national team led by a researcher at Penn Medicine has launched a study–funded by a $9.8 million grant from the NIH–to better understand clinical and biological processes that occur after transplant and lead to the development of these complications.
Read morePatients with a high risk of dying after surgery, including those with multiple chronic diseases, benefit from undergoing general or vascular procedures at a major teaching hospital as opposed to a non-teaching hospital, according to a study from researchers at Penn Medicine and CHOP.
Read moreWomen who are health policy or health services researchers face a significant disparity in social media influence compared to their male peers, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania. Although the average number of tweets among all researchers tend to be consistent, women trail behind men in follower counts, regardless of how active they are on Twitter. The findings, which hold implications for larger questions around gender disparities in academic medicine, are published today in JAMA Internal Medicine.
Read moreThe total amount of opioids dispensed per new opioid prescription decreased by 22 percent in Penn Medicine outpatient practices in New Jersey after the state passed a law limiting prescriptions to a five-day supply for new opioid prescriptions. Penn Medicine implemented an electronic health record (EMR) alert, or “nudge,” to notify clinicians if that limit had been reached. The study, published online today in the Journal of General Internal Medicine, is one of the first evaluations of a state law’s impact on prescribing outcomes, and is the first report of an EMR being used to make compliance with prescribing limits easier. Importantly, after the prescribing limit and alert went into effect there was no evidence to suggest pain control worsened.
Read moreA new scientific statement from the American Heart Association identifies the risks and benefits of using novel interventional devices compared to anticoagulation alone to treat patients with pulmonary embolism.
Read moreA new scientific statement from the American Heart Association identifies the risks and benefits of using novel interventional devices compared to anticoagulation alone to treat patients with pulmonary embolism.
Read morePenn Medicine has been awarded five grants from the NIH HEAL Initiative, totaling more than $22 million to apply scientific solutions to reverse the national opioid crisis.
Read moreWithin six months of the FDA’s move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.
Read more